TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
31.70
-1.66 (-4.98%)
At close: Jan 31, 2025, 4:00 PM
31.56
-0.14 (-0.44%)
After-hours: Jan 31, 2025, 7:45 PM EST
TG Therapeutics Employees
TG Therapeutics had 264 employees as of December 31, 2023. The number of employees increased by 38 or 16.81% compared to the previous year.
Employees
264
Change (1Y)
38
Growth (1Y)
16.81%
Revenue / Employee
$1,002,992
Profits / Employee
-$54,409
Market Cap
4.55B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
TGTX News
- 9 days ago - TG Therapeutics: Entering 2025 With Increased Investor Expectations - Seeking Alpha
- 11 days ago - TG Therapeutics: 2025 Revenues Will Smash Expectations - Seeking Alpha
- 18 days ago - TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst - Seeking Alpha
- 23 days ago - TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - 20 stocks likely to lag the S&P 500 over the next year — for this one reason - Market Watch
- 2 months ago - TG Therapeutics to Participate in the Evercore HealthCONx Conference - GlobeNewsWire
- 2 months ago - TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - GlobeNewsWire
- 3 months ago - TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates - Seeking Alpha